Zobrazeno 1 - 10 of 33 pro vyhledávání: '"T, Tedone"'
1
Association of pS2 (TFF1) release with breast tumour proliferative rate: in vitro and in vivo studies
Autor: Christopher Potten, Zbigniew Darzynkiewicz, Kohsuke Sasaki, S. J. Reshkin, T. Tedone, M. Correale, A. Mangia, V. Casavola, A. Paradiso
Publikováno v: Cell Proliferation. 32:107-118
Although cytosolic expression of the protein pS2 (TFFl) is considered to be a marker of oestrogen receptor (OR) function, there exists some clinical data to suggest an inverse relationship of cytosolic pS2 to tumour proliferation. Although secreted f
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c316c693ee848235fc13c886f2e158a1
https://doi.org/10.1046/j.1365-2184.1999.32230107.x
Zobrazit plný text záznamu
2
Differential responsiveness of proliferation and cytokeratin release to stripped serum and oestrogen in the human breast cancer cell line, MCF-7
Autor: T. Tedone, M. Correale, A. Paradiso, Stephan Joel Reshkin
Publikováno v: European Journal of Cancer. 32:849-856
In vitro research into hormone sensitivity and the relation to proliferation of cytokeratin release from cancer cells is scarce. Therefore, we examined the stimulation of proliferation and the release of cytokeratins in a breast cancer cell culture m
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022af650d79e02a2641e4529df57c1d6
https://doi.org/10.1016/0959-8049(95)00660-5
Zobrazit plný text záznamu
3
pS2—A new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer
Autor: Francesco Schittulli, Ines Abbate, M. Correale, M. De Lena, M. D. Musci, Annamaria Catino, A. Paradiso, T. Tedone, G. Gargano, C. D. Dragone
Publikováno v: Cell Biophysics. 22:101-110
Using a new immunoradiometric assay (ELSA pS2 Cis-France), a total of 200 cytosols obtained from primary breast tumors were examined for pS2 content, which is an estrogen-regulated protein actually studied as a marker of hormone sensitivity and favor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14ec127742f98c35a7cf109d41901b4
https://doi.org/10.1007/bf03033869
Zobrazit plný text záznamu
4
Cytokeratins and proliferation in breast cancer patients
Autor: A. Mangia, I Abbate, T. Tedone, A. Paradiso, M. Correale, Stephan J. Reshkin, Francesco Schittulli
Publikováno v: Europe PubMed Central
Tissue polypeptide antigen (TPA) was studied in 242 sera and 165 tumor cell cytosols (both evaluations in 67 cases) of breast cancer patients, for which proliferative activity, determined by the TLI technique, was also available. The TPA serum and tu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4010bdc751fabda0e9fe970bf426073f
https://doi.org/10.3892/ijo.9.5.1007
Zobrazit plný text záznamu
6
Cytosolic levels of estrogen-regulated pS2 protein in breast cancer: correlation with tumor proliferative activity
Autor: C. D. Dragone, Francesco Schittulli, T. Tedone, M. Correale, A. Paradiso, Ines Abbate, Anita Mangia, R. Filotico, M. De Lena
Publikováno v: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 14(1)
Using a new immunoradiometric assay, a total of 100 cytosols obtained from primary breast tumors were examined for content of pS2, an estrogen-regulated protein. In our series, the median pS2 value was 5 ng/mg protein cytosol which was used as the cu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d920fd1bcb5a36c530fd6a3213f1b88
https://pubmed.ncbi.nlm.nih.gov/8493448
Zobrazit plný text záznamu
7
Serum and cytosolic levels of CA549 in breast cancer patients
Autor: M, Correale, I, Abbate, C D, Dragone, T, Tedone, G, Gargano, A, Catino, A, Paradiso, L, Addabbo, M D, Musci, M, De Lena
Publikováno v: Clinical and experimental obstetricsgynecology. 20(4)
CA 549 is a new mucinous circulating tumor marker recognized by two monoclonal antibodies (BC4E549 and BC4N154) recently proposed for breast cancer. In this report we compared the levels of CA 549 and CA 15.3, the best known biomarker for breast canc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e5daf196b7f6a7d70888975b40de1226
https://pubmed.ncbi.nlm.nih.gov/8281711
Zobrazit plný text záznamu
8
Serum levels of TAG 72 and CA 15.3 in patients with gynaecological neoplasms
Autor: M, Correale, I, Abbate, A, Catino, T, Tedone, M D, Musci, D, Dragone, G, Gargano, G, Izzi, A, Cramarossa
Publikováno v: European journal of gynaecological oncology. 13
In the present report we have evaluated two new serum tumour markers identified by monoclonal antibodies: TAG 72 and CA 15.3 in 62 patients with gynaecological carcinomas, in prevalence ovarian and 36 women with benign gynaecological diseases. Serum
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::576881557c3cc85434e9f80f04815980
https://pubmed.ncbi.nlm.nih.gov/1511720
Zobrazit plný text záznamu
9
Tumor necrosis factor and soluble interleukin-2 receptor: two immunological biomarkers in female neoplasms
Autor: I, Abbate, M, Correale, G, Gargano, T, Tedone, G, Izzi, A, Catino, M D, Musci, D, Dragone, A, Cramarossa
Publikováno v: European journal of gynaecological oncology. 13
In this study we have evaluated two new immunological parameters, soluble IL-2 receptor (s IL-2 R) and TNF, in 119 patients with female solid neoplasms (47 ovarian and 72 breast cancer). Our data demonstrate that both these markers have mean serum le
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7dc9817c5522fc4f5e8cc8fb37812a8b
https://pubmed.ncbi.nlm.nih.gov/1511722
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje